| Klaus D Mergener, MD | |
|
840 E Hill Ave, Moses Lake, WA 98837-2238 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Klaus D Mergener |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 840 E Hill Ave, Moses Lake, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578537031 | NPI | - | NPPES |
| 781604 | Medicaid | WA | |
| MD00039380 | Other | WA | WA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00039380 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera Mckennan Hospital & University Health Center | Sioux falls, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Avera Mckennan | 0345157103 | 848 |
News Archive
Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. In recognition of May's Skin Cancer Awareness Month and Melanoma Monday on May 5th, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings.
A long-sought goal of creating particles that can emit a colorful fluorescent glow in a biological environment, and that could be precisely manipulated into position within living cells, has been achieved by a team of researchers at MIT and several other institutions. The finding is reported this week in the journal Nature Communications.
Melanoma is an aggressive form of skin cancer that has been increasing in incidence in adults over the past 40 years. Although pediatric melanoma is rare (5-6 children per million), most studies indicate that incidence has been increasing. In a new study scheduled for publication in The Journal of Pediatrics, researchers found that the incidence of pediatric melanoma in the United States actually has decreased from 2004-2010.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
New research suggests that obesity changes how airway muscles function, increasing the risk of developing asthma. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
› Verified 4 days ago
| Entity Name | Avera Mckennan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003389206 PECOS PAC ID: 0345157103 Enrollment ID: O20031110000117 |
News Archive
Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. In recognition of May's Skin Cancer Awareness Month and Melanoma Monday on May 5th, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings.
A long-sought goal of creating particles that can emit a colorful fluorescent glow in a biological environment, and that could be precisely manipulated into position within living cells, has been achieved by a team of researchers at MIT and several other institutions. The finding is reported this week in the journal Nature Communications.
Melanoma is an aggressive form of skin cancer that has been increasing in incidence in adults over the past 40 years. Although pediatric melanoma is rare (5-6 children per million), most studies indicate that incidence has been increasing. In a new study scheduled for publication in The Journal of Pediatrics, researchers found that the incidence of pediatric melanoma in the United States actually has decreased from 2004-2010.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
New research suggests that obesity changes how airway muscles function, increasing the risk of developing asthma. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Klaus D Mergener, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Klaus D Mergener, MD 840 E Hill Ave, Moses Lake, WA 98837-2238 Ph: (509) 663-8711 |
News Archive
Skin cancer is the most common form of cancer in the United States, with one in five Americans developing it over the course of their lives. It's also one of the most preventable types of cancers. In recognition of May's Skin Cancer Awareness Month and Melanoma Monday on May 5th, Mount Sinai Health System experts are arming the public with vital tips on prevention and offering FREE skin cancer screenings.
A long-sought goal of creating particles that can emit a colorful fluorescent glow in a biological environment, and that could be precisely manipulated into position within living cells, has been achieved by a team of researchers at MIT and several other institutions. The finding is reported this week in the journal Nature Communications.
Melanoma is an aggressive form of skin cancer that has been increasing in incidence in adults over the past 40 years. Although pediatric melanoma is rare (5-6 children per million), most studies indicate that incidence has been increasing. In a new study scheduled for publication in The Journal of Pediatrics, researchers found that the incidence of pediatric melanoma in the United States actually has decreased from 2004-2010.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
New research suggests that obesity changes how airway muscles function, increasing the risk of developing asthma. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
› Verified 4 days ago
Bethany Mulder, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 605 S Coolidge St, Moses Lake, WA 98837 Phone: 509-765-0674 Fax: 509-764-0344 | |
Evan Michael Graham, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-765-0216 | |
Dr. Tony E Yusuf, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Dr. Stacy Kay Tong, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 | |
Dr. David Thurn Earl, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1550 S Pioneer Way, Suite 200, Moses Lake, WA 98837 Phone: 509-765-1538 Fax: 509-765-7508 | |
Philip D Buckley, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 |